International Medical Center of Biomaterials Processing and Cryostorage (MOEX:GEMA)

MOEX:GEMA Income Statement

Financials in millions RUB. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	348.6	283.51	254.68	265.89	242.63
Revenue Growth (YoY)	22.96%	11.32%	-4.22%	9.59%	1.69%
Cost of Revenue	58.72	47.95	51.67	61.82	30.87
Gross Profit	289.89	235.56	203	204.07	211.76
Selling, General & Admin	111.74	86.2	64.41	65.52	53.69
Amortization of Goodwill & Intangibles	-	-	-	-	2.1
Other Operating Expenses	-	-	-	-	5.81
Operating Expenses	111.74	86.2	64.41	66.17	69.9
Operating Income	178.15	149.36	138.6	137.9	141.86
Interest Expense	-34.57	-33.56	-17.62	-3.52	-6.84
Interest & Investment Income	23.85	11.98	10.54	17.48	2.24
Earnings From Equity Investments	-	6.53	-	-	-
Currency Exchange Gain (Loss)	-	-	-	-	-0.09
Other Non Operating Income (Expenses)	-16.22	-8.73	-32	-18.7	-14.39
EBT Excluding Unusual Items	151.22	125.58	99.52	133.17	122.77
Gain (Loss) on Sale of Assets	-	0.2	-1.35	-4	-
Pretax Income	151.22	125.78	98.17	129.17	122.77
Net Income	151.22	125.78	98.17	129.17	122.77
Preferred Dividends & Other Adjustments	-	-	-	-21.57	-
Net Income to Common	151.22	125.78	98.17	150.74	122.77
Net Income Growth	20.22%	28.13%	-24.00%	5.21%	2.95%
Shares Outstanding (Basic)	-	15	15	15	15
Shares Outstanding (Diluted)	-	15	15	15	15
Shares Change (YoY)	-	-	-0.00%	0.00%	11.11%
EPS (Basic)	-	8.42	6.58	10.10	8.22
EPS (Diluted)	-	8.42	6.58	10.10	8.22
EPS Growth	-	28.13%	-34.88%	22.79%	-7.35%
Free Cash Flow	236.53	209.59	231.83	239.82	132.26
Free Cash Flow Per Share	-	14.04	15.53	16.06	8.86
Dividend Per Share	-	6.420	8.022	8.650	-
Dividend Growth	-	-19.97%	-7.26%	-	-
Gross Margin	83.16%	83.09%	79.71%	76.75%	87.28%
Operating Margin	51.10%	52.68%	54.42%	51.86%	58.47%
Profit Margin	43.38%	44.37%	38.55%	56.69%	50.60%
Free Cash Flow Margin	67.85%	73.93%	91.03%	90.20%	54.51%
EBITDA	186.43	157.64	142.41	142.04	148.31
EBITDA Margin	53.48%	55.60%	55.92%	53.42%	61.13%
D&A For EBITDA	8.28	8.28	3.81	4.14	6.45
EBIT	178.15	149.36	138.6	137.9	141.86
EBIT Margin	51.10%	52.68%	54.42%	51.86%	58.47%
Revenue as Reported	-	-	-	-	242.63
Advertising Expenses	-	23.97	17.11	15.86	8.17

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.